The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Renzi David since 2015.
The trader's CIK number is 1631294.
At the time of the last reporting, Renzi David was the President & CEO of Kalvista Pharmaceuticals, Inc.. (stock ticker symbol KALV).
Also see all insider trading activities at Kalvista Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | CBYL | 0 | $0 | 0 | $0 | 36,640 | $287,257 |
| 2015 | CBYL | 0 | $0 | 10,000 | $37,000 | 10,000 | $5,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-11-21 | CBYL | Option Ex | 36,640 | 7.84 | 287,257 |
| 2015-12-30 | CBYL | Sale | 10,000 | 3.70 | 37,000 |
| 2015-12-30 | CBYL | Option Ex | 10,000 | .56 | 5,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Renzi David (President & CEO of Kalvista Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.